Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024)
Zoetis' (ZTS) quarterly Short-Term Debt issuances came in at -$24.0 million in Q2 2024, down 2300.0% year-on-year from $1.1 million in Q3 2023, and down 214.29% on a QoQ basis from $21.0 million in Q1 2024.
Zoetis (ZTS) Short-Term Debt issuances (2013 - 2024) Analysis & Trends
Zoetis (ZTS) has 12 years of Short-Term Debt issuances data on file, last reported at -$24.0 million in Q2 2024.
- On a quarterly basis, Short-Term Debt issuances fell 2300.0% year-over-year to -$24.0 million in Q2 2024; TTM through Mar 2025 was -$24.0 million, a 214.29% decrease from a year earlier, with the FY2024 full-year figure at -$3.0 million, down 400.0% from the prior year.
- Short-Term Debt issuances for Q2 2024 stood at -$24.0 million, down from $21.0 million in the prior quarter.
- Over the last five years, Short-Term Debt issuances for ZTS reached as high as $21.0 million in Q1 2024 and fell as low as -$24.0 million in Q2 2024.
- Historically, Short-Term Debt issuances has averaged $0.0 across 5 years, with a median of $1.0 million in 2020.
- On a YoY basis, Short-Term Debt issuances climbed as much as 2000.0% in 2024 and fell as far as 2300.0% in 2024.
- Year by year, Short-Term Debt issuances stood at $3.0 million in 2020, then slumped by 233.33% to -$4.0 million in 2021, then soared by 75.0% to -$1.0 million in 2022, then jumped by 200.0% to $1.0 million in 2023, then sank by 2500.0% to -$24.0 million in 2024.
- Per Business Quant data, the three most recent Short-Term Debt issuances figures were -$24.0 million in Q2 2024, $21.0 million in Q1 2024, and $1.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -24.00 Mn |
| Jun 30, 2024 | -24.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Mar 31, 2024 | 21.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Dec 31, 2022 | -1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Sep 30, 2021 | -4.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Dec 31, 2020 | 3.00 Mn |